Pharma & Biotech

Pharma & Biotech

As the pace of innovation in precision therapies accelerates, so do the challenges in bringing these transformative therapies to patients. Navigating evolving clinical trial, regulatory, manufacturing, and market access landscapes requires precise market insights and novel strategies.

Client Results

Our Impact

See how we’ve helped ambitious clients achieve extraordinary outcomes.

See ALL Client Results
Biomarker and Diagnostic Strategy
Due Diligence
KOL Identification
Revenue Projection
Go-to-Market Strategy
Pharma & Biotech
Internal Lab Buildout Strategy
A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology
Voice-Of-Customer Research
Due Diligence
Pharma & Biotech
Synthetic mRNA Production Landscape Assessment
A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy
Voice-Of-Customer Research
Competitive Analysis
Pharma & Biotech
AI Patient Recruitment Go-to-Market Strategy
A healthcare technology startup wanted to conduct an assessment of potential go-to-market strategies for their AI analytical patient recruitment tool
Voice-Of-Customer Research
Go-to-Market Strategy
Pharma & Biotech
Healthcare IT Solution Market Opportunity
A leading pharmaceutical & clinical diagnostics manufacturer wanted to understand the market opportunity for a novel multidisciplinary cancer conference IT support solution
Voice-Of-Customer Research
Go-to-Market Strategy
Featured Team
Andrew Aijian
Partner
David Cavanaugh
Founding Partner
Carl Schoellhammer
Senior Project Leader
Colin Enderlein
Senior Project Leader
Data & Platforms
Platform
BioTrack
BioTrack is the all-in-one data aggregator for busy life science professionals. Discover the latest life science news, publications, and clinical trials that relate to your interests and workflows.
Platform
BioTrack
BioTrack is the all-in-one data aggregator for busy life science professionals. Discover the latest life science news, publications, and clinical trials that relate to your interests and workflows.
Platform
BioTrack
BioTrack is the all-in-one data aggregator for busy life science professionals. Discover the latest life science news, publications, and clinical trials that relate to your interests and workflows.
Platform
Dexter Expert Network
Browse our network of life sciences advisors and schedule 1:1s or pulse surveys to gain the targeted insights you need to test the market, launch a product, or discover a new opportunity.
Platform
Dexter Expert Network
Browse our network of life sciences advisors and schedule 1:1s or pulse surveys to gain the targeted insights you need to test the market, launch a product, or discover a new opportunity.
Platform
Dexter Expert Network
Browse our network of life sciences advisors and schedule 1:1s or pulse surveys to gain the targeted insights you need to test the market, launch a product, or discover a new opportunity.
Market Report
Global Oncology Liquid Biopsy Manufacturing Market
The diagnostics market has grown rapidly due to significant investment in liquid biopsy companies. The subsequent proliferation of liquid biopsy companies (100 companies globally) has drawn both attention and skepticism over the future state of the market.
Market Report
Global Oncology Liquid Biopsy Manufacturing Market
The diagnostics market has grown rapidly due to significant investment in liquid biopsy companies. The subsequent proliferation of liquid biopsy companies (100 companies globally) has drawn both attention and skepticism over the future state of the market.
Market Report
Global Oncology Liquid Biopsy Manufacturing Market
The diagnostics market has grown rapidly due to significant investment in liquid biopsy companies. The subsequent proliferation of liquid biopsy companies (100 companies globally) has drawn both attention and skepticism over the future state of the market.
Proprietary Database
I/O BioMAP
The DeciBio Immuno-Oncology Biomarker Analysis Platform (I/O BioMAP) is a dynamic, interactive database of biomarkers for cancer immunotherapies in clinical trials.
Proprietary Database
I/O BioMAP
The DeciBio Immuno-Oncology Biomarker Analysis Platform (I/O BioMAP) is a dynamic, interactive database of biomarkers for cancer immunotherapies in clinical trials.
Proprietary Database
I/O BioMAP
The DeciBio Immuno-Oncology Biomarker Analysis Platform (I/O BioMAP) is a dynamic, interactive database of biomarkers for cancer immunotherapies in clinical trials.
Market Report
Oncology Biomarker Market Assessment
Oncology biomarker testing is now used for applications including treatment selection, prognosis, and monitoring drug response / tumor progression. We forecast that the cancer biomarker testing market size will grow at ~11% p.a. from ~$2.7B in 2017 to ~$3.7B in 2020.
Market Report
Oncology Biomarker Market Assessment
Oncology biomarker testing is now used for applications including treatment selection, prognosis, and monitoring drug response / tumor progression. We forecast that the cancer biomarker testing market size will grow at ~11% p.a. from ~$2.7B in 2017 to ~$3.7B in 2020.
Market Report
Oncology Biomarker Market Assessment
Oncology biomarker testing is now used for applications including treatment selection, prognosis, and monitoring drug response / tumor progression. We forecast that the cancer biomarker testing market size will grow at ~11% p.a. from ~$2.7B in 2017 to ~$3.7B in 2020.
Latest Insights
Pharma & Biotech
Q&A with Suchismita Acharya – Founder and CEO of AyuVis Research
We had the opportunity to speak with Suchismita Acharya about her experiences starting AyuVis Research. AyuVis Research is a preclinical stage pharmaceutical company in Fort Worth, TX
August 24, 2021
Pharma & Biotech
COVID’s Effect on mRNA Assets, Part II: Experience (and Quality) Matters
With renewed interest in disparate applications and the subsequent flood of newcomers to mRNA asset development, the focus on quality and experience with regard to mRNA is more important than ever.
August 25, 2021
Pharma & Biotech
Lessons in Digital Health Platform Acquisition from IBM’s Watson
After nearly a decade of disappointment after disappointment, IBM announced earlier this year that they are looking to sell Watson Health.
August 25, 2021
Pharma & Biotech
COVID’s Effect on mRNA Assets, Part I: Vaccines & Delivery
With a global pandemic to fight, the speed, efficacy, and efficiency of mRNA vaccine research, development, and manufacturing have been proven invaluable.
August 25, 2021
View All Insights

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Precision Medicine. Precision Insights.
© DeciBio 2021. All rights reserved.
Privacy | Terms & Conditions